, Volume 192, Issue 3, pp 425–440 | Cite as

A triazolam/amphetamine dose–effect interaction study: dissociation of effects on memory versus arousal

Original Investigation



In addition to producing robust memory impairment, benzodiazepines also induce marked sedation. Thus, it is possible that the observed amnestic effects are secondary to more global sedative effects and do not reflect a specific primary benzodiazepine effect on memory mechanisms.


The objective was to use the nonspecific stimulant d-amphetamine to dissociate the sedative and memory-impairing effects of the benzodiazepine triazolam.

Materials and methods

Single oral doses of placebo, triazolam alone (0.25, 0.50 mg/70 kg), d-amphetamine sulfate alone (20, 30 mg/70 kg), and triazolam (0.25, 0.50 mg/70 kg) and d-amphetamine sulfate (20, 30 mg/70 kg) conjointly (at all dose combinations) were administered to 18 healthy adult participants across nine sessions in a double-blind, staggered-dosing, crossover design. In addition to standard data analyses, analyses were also conducted on z-score standardized data, enabling effects to be directly compared across measures.


Relative to the sedative measures, the memory measures generally exhibited a pattern of less reversal of triazolam’s effects by d-amphetamine. The memory measures ranged in degree of reversal such that the most reversal was observed for reaction time on the n-back working memory task, and the least reversal was observed for accuracy on the Sternberg working memory task, with most measures showing an overall pattern of partial reversal.


Benzodiazepines have specific effects on memory that are not merely a by-product of the drugs’ sedative effects, and the degree to which sedative effects contribute to the amnestic effects varies as a function of the particular memory process being assessed.


Triazolam Amphetamine Memory Arousal Sedative 


  1. Baddeley AD (1992) Working memory: the interface between memory and cognition. J Cogn Neurosci 4:281–288Google Scholar
  2. Bishop KI, Curran HV (1995) Psychopharmacological analysis of implicit and explicit memory: a study with lorazepam and the benzodiazepine antagonist flumazenil. Psychopharmacology 121:267–278PubMedCrossRefGoogle Scholar
  3. Blin O, Simon N, Jouve E, Habib M, Gayraud D, Durand A, Bruguerolle B, Pisano P (2001) Pharmacokinetic and pharmacodynamic analysis of sedative and amnesic effects of lorazepam in healthy volunteers. Clin Neuropharmacol 24:71–81PubMedCrossRefGoogle Scholar
  4. Buffett-Jerrott SE, Stewart SH (2002) Cognitive and sedative effects of benzodiazepine use. Curr Pharm Des 8:45–58PubMedCrossRefGoogle Scholar
  5. Burns JT, House RF, Fensch FC, Miller JG (1967) Effects of magnesium pemoline and dextroamphetamine on human learning. Science 155:849–851PubMedCrossRefGoogle Scholar
  6. Curran HV (1991) Benzodiazepines, memory and mood: a review. Psychopharmacology 105:1–8PubMedCrossRefGoogle Scholar
  7. Curran HV (2000) Psychopharmacological approaches to human memory. In: Gazzaniga MS (ed) The new cognitive neurosciences, 2nd edn. Boston, MIT, pp 797–804Google Scholar
  8. Curran HV, Birch B (1991) Differentiating the sedative and amnestic effects of benzodiazepines: a study with midazolam and the benzodiazepine antagonist, flumazenil. Psychopharmacology 103:519–523PubMedCrossRefGoogle Scholar
  9. Curran HV, Bond A, O’Sullivan G, Bruce M, Marks I, Lelliot P, Shine P, Lader M (1994) Memory functions, alprazolam and exposure therapy: a controlled longitudinal study of patients with agoraphobia and panic disorder. Psychol Med 24:969–976PubMedGoogle Scholar
  10. Curran HV, Pooviboonsuk P, Dalton JA, Lader MH (1998) Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology 135:27–36PubMedCrossRefGoogle Scholar
  11. D’Esposito M, Postle BR, Ballard D, Lease J (1999) Maintenance versus manipulation of information held in working memory: an event-related fMRI study. Brain Cogn 41:66–86PubMedCrossRefGoogle Scholar
  12. Flavell JH (1971) What is memory development the development of? Hum Dev 14:272–278CrossRefGoogle Scholar
  13. Fleming K, Bigelow LB, Weinberger DR, Goldberg TE (1995) Neuropsychological effects of amphetamine may correlate with personality characteristics. Psychopharmacol Bull 31:357–362PubMedGoogle Scholar
  14. Ghoneim MM (2004a) Drugs and human memory (part 1): clinical, theoretical, and methodologic issues. Anesthesiology 100:987–1002PubMedCrossRefGoogle Scholar
  15. Ghoneim MM (2004b) Drugs and human memory (part 2): clinical, theoretical, and methodologic issues. Anesthesiology 100:1277–1297PubMedCrossRefGoogle Scholar
  16. Ghoneim MM, Mewaldt SP, Berie JL, Hinrichs V (1981) Memory and performance effects of single and 3 week administration of diazepam. Psychopharmacology 73:147–151PubMedCrossRefGoogle Scholar
  17. Goodman LA, Kruskal WH (1954) Measures of association for cross-classifications. J Am Stat Assoc 49:732–764CrossRefGoogle Scholar
  18. Green JF, McElholm A, King DJ (1996) A comparison of the sedative and amnestic effects of chlorpromazine and lorazepam. Psychopharmacology 128:67–73PubMedCrossRefGoogle Scholar
  19. Griffiths RR, Bigelow GE, Liebson I (1983) Differential effects of diazepam and pentobarbital on mood and behavior. Arch Gen Psychiatry 40:865–873PubMedGoogle Scholar
  20. Hollister LE, Müller-Oerlinghausen B, Rickels K, Shader RI (1993) Clinical uses of benzodiazepines. J Clin Psychopharmacol 13:1S–169SPubMedCrossRefGoogle Scholar
  21. Hommer D, Weingartner H, Breier A (1993) Dissociation of benzodiazepine-induced amnesia from sedation by flumazenil. Psychopharmacology 112:455–460PubMedCrossRefGoogle Scholar
  22. Hurst PM, Radlow R, Chubb NC, Bagley SK (1969) Effects of d-amphetamine on acquisition, persistence, and recall. Am J Psychol 82:307–319PubMedCrossRefGoogle Scholar
  23. Jonides J, Schumacher EH, Smith EE, Lauber EJ, Awh E, Minoshima S, Koeppe RA (1997) Verbal working memory load affects regional brain activation as measured by PET. J Cogn Neurosci 9:462–475CrossRefGoogle Scholar
  24. Justice AJH, de Wit H (2000a) Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol Biochem Behav 66:509–515PubMedCrossRefGoogle Scholar
  25. Justice AJH, de Wit H (2000b) Acute effects of estradiol pretreatment on the response to d-amphetamine in women. Neuroendocrinology 71:51–59PubMedCrossRefGoogle Scholar
  26. Kennedy RS, Odenheimer RC, Baltzley DR, Dunlap WP, Wood CD (1990) Differential effects of scopolamine and amphetamine on microcomputer-based performance tests. Aviat Space Environ Med 61:615–621PubMedGoogle Scholar
  27. Keppel G (1991) Design and analysis: a research’s handbook, 3rd edn. Prentice Hall, Englewood CliffsGoogle Scholar
  28. Kirk T, Roache JD, Griffiths RR (1990) Dose–response evaluation of the amnestic effects of triazolam and pentobarbital in normal subjects. J Clin Psychopharmacol 10:160–167PubMedCrossRefGoogle Scholar
  29. Kornetsky C (1958) Effects of meprobamate, phenobarbital and dextroamphetamine on reaction time and learning in man. J Pharmacol Exp Ther 123:216–219PubMedGoogle Scholar
  30. Mattay VS, Callicott JH, Bertolino A, Heaton I, Frank JA, Coppola R, Berman KF, Goldberg TE, Weinberger DR (2000) Effects of dextroamphetamine on cognitive performance and cortical activation. NeuroImage 12:268–275PubMedCrossRefGoogle Scholar
  31. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, Kolachana B, Callicott JH, Weinberger DR (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100:6186–6191PubMedCrossRefGoogle Scholar
  32. McLeod DR, Griffiths RR, Bigelow GE, Yingling J (1982) An automated version of the digit symbol substitution test (DSST). Behav Res Meth Instrum 14:463–466Google Scholar
  33. Metcalfe J, Shimamura AP (1994) Metacognition: knowing about knowing. Cambridge, MITGoogle Scholar
  34. Mintzer MZ, Griffiths RR (2003) Lorazepam and scopolamine: a single-dose comparison of effects on human memory and attentional processes. Exp Clin Psychopharmacol 11:56–72PubMedCrossRefGoogle Scholar
  35. Mintzer MZ, Griffiths RR, Contoreggi C, Kimes AS, London ED, Ernst M (2001) Effects of triazolam on brain activity during episodic memory encoding: a PET study. Neuropsychopharmacology 25:744–756PubMedCrossRefGoogle Scholar
  36. Neave N, Reid C, Scholey AB, Thompson JM, Moss M, Ayre G, Wesnes K, Girdler NM (2000) Dose-dependent effects of flumazenil on cognition, mood, and cardio-respiratory physiology in healthy volunteers. Br Dent J 189:668–674PubMedCrossRefGoogle Scholar
  37. Nelson TO (1984) A comparison of current measures of the accuracy of feeling of knowing predictions. Psychol Bull 95:109–133PubMedCrossRefGoogle Scholar
  38. Postle BR, Berger JS, D’Esposito M (1999) Functional neuroanatomical double dissociation of mnemonic and executive control processes contributing to working memory performance. Proc Natl Acad Sci USA 96:12959–12964PubMedCrossRefGoogle Scholar
  39. Preston KL, Bigelow GE, Liebson IA (1989) Antagonist effects of nalbuphine in opioid-dependent human volunteers. J Pharmacol Exp Ther 248:929–937PubMedGoogle Scholar
  40. Rapoport JL, Buchsbaum MS, Weingartner H, Zahn TP, Ludlow C, Mikkelsen EJ (1980) Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. Arch Gen Psychiatry 37:933–943PubMedGoogle Scholar
  41. Robbins TW, Everitt BJ (1982) Functional studies of the central catecholamines. Int Rev Neurobiol 23:303–365PubMedCrossRefGoogle Scholar
  42. Smirne S, Ferini-Strambi L, Pirola R, Tancredi O, Franceschi M, Pinto P, Bareggi SR (1989) Effects of flunitrazepam on cognitive functions. Psychopharmacology 98:251–256PubMedCrossRefGoogle Scholar
  43. Snodgrass JG, Corwin J (1988) Pragmatics of measuring recognition memory: applications to dementia and amnesia. J Exp Psychol Gen 117:34–50PubMedCrossRefGoogle Scholar
  44. Soetens S, Casaer S, D’Hooge R, Hueting JE (1995) Effect of amphetamine on long-term retention of verbal material. Psychopharmacology 119:155–162PubMedCrossRefGoogle Scholar
  45. Solanto MV (1998) Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94:127–152PubMedCrossRefGoogle Scholar
  46. Sternberg S (1969) The discovery of processing stages: extensions of Donder’s method. Acta Psychol 30:276–315CrossRefGoogle Scholar
  47. Tata PR, Rollings J, Collins M, Pickering A, Jacobson RR (1994) Lack of cognitive recovery following withdrawal from long-term benzodiazepine use. Psychol Med 24:203–213PubMedCrossRefGoogle Scholar
  48. Thorndike EL, Lorge I (1944) The teacher’s word book of 30,000 words. Teacher’s College, Columbia University, New YorkGoogle Scholar
  49. Tulving E (1972) Episodic and semantic memory. In: Tulving E, Donaldson W (eds) Organization of memory. New York, Academic, pp 381–403Google Scholar
  50. Tulving E (1983) Elements of episodic memory. Oxford University, New YorkGoogle Scholar
  51. Veselis RA, Reinsel RA, Feshchenko VA (2001) Drug-induced amnesia is a separate phenomenon from sedation: electrophysiologic evidence. Anesthesiology 95:896–907PubMedCrossRefGoogle Scholar
  52. Veselis RA, Reinsel RA, Feshchenko VA, Wronski M (1997) The comparative amnestic effects of midazolam, propofol, thiopental, and fentanyl at equisedative concentrations. Anesthesiology 87:749–764PubMedCrossRefGoogle Scholar
  53. Weingartner HJ, Sirocco K, Rawlings R, Joyce E, Hommer D (1995) Dissociations in the expression of the sedative effects of triazolam. Psychopharmacology 119:27–33PubMedCrossRefGoogle Scholar
  54. Weiss B, Laties VG (1962) Enhancement of human performance by caffeine and the amphetamines. Pharmacol Rev 14:1–36PubMedGoogle Scholar
  55. Weitzner M (1965) Manifest anxiety, amphetamine, and performance. J Psychol 60:71–79PubMedGoogle Scholar
  56. White TL, Justice AJH, de Wit H (2002) Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav 73:729–741PubMedCrossRefGoogle Scholar
  57. Williams EJ (1949) Experimental designs balanced for the estimation of residual effects of treatments. Aust J Sci Res 2:149–168Google Scholar
  58. Woods JH, Katz JL, Winger G (1992) Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 44:151–347PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  1. 1.Department of Psychiatry and Behavioral Sciences, Behavioral Biology Research CenterJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.Department of NeuroscienceJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations